Fabrication of g-CN Nanomesh-Anchored Amorphous NiCoPO: Tuned Cycling Life and the Dynamic Behavior of a Hybrid Capacitor.

Developing a novel electrode material with better electrochemical behavior and extended cyclability is a major issue in the field of hybrid capacitors. In this work, we propose a novel strategy for the facile synthesis of nickel-cobalt pyrophosphate nanoparticles anchored on graphitic carbon nitride (NiCoPO/g-CN) via the simple solvothermal method. Field emission scanning electron microscopy and transmission electron microscopy analysis revealed the uniform anchoring of NiCoPO nanocomposite on g-CN nanosheets.

The 1 μg cosyntropin test in normal individuals: A reappraisal.

Background: The 1μg cosyntropin test has some advantages over the 250μg test as a test of adrenal function. One of the concerns regarding the 1 μg test includes stability of the cosyntropin when reconstituted and stored. Classically the 5(th) percentile responses to cosyntropin in normal individuals have been used to define a normal response.

Baseline characteristics of the Indian cohort from the IMPROVE study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes.

Introduction: The IMPROVE study is an openlabel, nonrandomized, observational study aimed at determining the safety and efficacy of biphasic insulin aspart 30 (BIAsp 30) treatment in subjects with type 2 diabetes from 11 countries. Here, we report the baseline data of the Indian cohort.

Methods: All subjects with type 2 diabetes requiring insulin and considered suitable for BIAsp 30 therapy based on their physician's clinical judgment were eligible to enter the study.

Hidradenitis suppurativa treated with finasteride.

Background: Hidradenitis suppurativa (HS) is a distressing condition for which no satisfactory treatment is available. Studies on hormonal mechanisms responsible for HS point towards altered end-organ sensitivity, probably related to the enzyme 5a reductase that converts testosterone to dihydrotestosterone. Finasteride, an inhibitor of type II 5a reductase, has been reported to be effective in recalcitrant HS.